FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Federal Drug Wholesaler Standards Sought

[ Price : $8.95]

Five stakeholders reiterate positions and add new insights from an FDA meeting on progress made toward implementing product identi...

Groups Suggest Changes to Software 510(k) Guidance

[ Price : $8.95]

Stakeholders say they appreciate an FDA draft guidance on when medical device software changes require a new 510(k) and offer prop...

Praise for Biosim User Fee Agreement

[ Price : $8.95]

Three industry stakeholders praise the agreement reached for reauthorization of the Biosimilars User Fee Act.

FDA Moves to Improve Hearing Aid Accessibility

[ Price : $8.95]

FDA says it will no longer require medical evaluations and signed waivers before consumers purchase a hearing aid, and it is consi...

CFSAN Posting Adverse Event Data Files

[ Price : $8.95]

Federal Register Notice: FDA makes available data extracted from adverse event reports from 2004 to the present for food (includin...

Trump Team Looking at Non-Medical Person to Lead FDA

[ Price : $8.95]

President-elect Donald Trumps reportedly considers a Silicon Valley venture capital manager to take the helm at FDA.

FDA Determines Regulatory Review Period for Mercks Gardasil 9

[ Price : $8.95]

Federal Register Notice: FDA determines the regulatory review period for Mercks Gardasil 9 (human papillomavirus 9-valent vaccine,...

FDA Issues Lengthy 483 to Sun Pharmaceutical

[ Price : $8.95]

Bloomberg News reports that a recent FDA inspection at Suns plant in Halol, India, resulted in a 14-page FDA-483.

Medtronic, Fitbit Partner on Diabetes Tracker

[ Price : $8.95]

Medtronic and Fitbit partner on a mobile app to help Type 2 diabetes patients track glucose levels and physical activity.

Voluntis Diabetes Management Tool Cleared

[ Price : $8.95]

FDA grants Voluntis 510(k) clearance for Insulia, a digital solution intended to support the effective management of Type 2 adult ...